First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension
Información
- DOI:
- https://doi.org/10.1002/14651858.CD008170Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 octubre 2009see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Hipertensión
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
James Wright formulated the idea for the review and developed the basis for the protocol.
Wenlu Tang is taking the lead role in searching, identifying and assessing studies, in data extraction and analyses, and in writing up the review.
Gavin Wong and Marco Perez will aid in developing optimal search strategies, identifying trials, assessing studies and in data extraction.
Sources of support
Internal sources
-
University of British Columbia, Department of Anesthesiology, Pharmacology & Therapeutics, Canada.
External sources
-
No sources of support supplied
Declarations of interest
None declared.
Acknowledgements
The authors would like to acknowledge the help provided by the Cochrane Hypertension Group.
Version history
| Published | Title | Stage | Authors | Version |
| 2018 Nov 14 | First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension | Review | Yu Jie Chen, Liang Jin Li, Wen Lu Tang, Jia Yang Song, Ru Qiu, Qian Li, Hao Xue, James M Wright | |
| 2015 Jan 11 | First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension | Review | Hao Xue, Zhuang Lu, Wen Lu Tang, Lu Wei Pang, Gan Mi Wang, Gavin WK Wong, James M Wright | |
| 2009 Oct 07 | First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension | Protocol | Wenlu Tang, Gavin WK Wong, Marco I Perez, James M Wright | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
- Angiotensin-Converting Enzyme Inhibitors [adverse effects, *therapeutic use];
- Antihypertensive Agents [adverse effects, *therapeutic use];
- Calcium Channel Blockers [adverse effects, therapeutic use];
- Cause of Death;
- Heart Failure [chemically induced, mortality, prevention & control];
- Hypertension [*drug therapy, mortality];
- Kidney Failure, Chronic [epidemiology];
- Myocardial Infarction [epidemiology];
- Randomized Controlled Trials as Topic;
- Renin-Angiotensin System [*drug effects];
- Sodium Chloride Symporter Inhibitors [adverse effects, therapeutic use];
- Stroke [chemically induced, prevention & control];
Medical Subject Headings Check Words
Aged; Humans;
